• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度严重真菌感染的负担

Burden of Serious Fungal Infections in India.

作者信息

Ray Animesh, Aayilliath K Adarsh, Banerjee Sayantan, Chakrabarti Arunaloke, Denning David W

机构信息

Department of Medicine, AIIMS, New Delhi, India.

Department of Microbiology, AIIMS, Kalyani, West Bengal, India.

出版信息

Open Forum Infect Dis. 2022 Dec 26;9(12):ofac603. doi: 10.1093/ofid/ofac603. eCollection 2022 Dec.

DOI:10.1093/ofid/ofac603
PMID:36589484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9792086/
Abstract

BACKGROUND

Fungal disease is frequent in India, but its incidence and prevalence are unclear. This review aims at defining the frequency or burden of various fungal infections in India.

METHODS

A systematic review of the literature on the PubMed, Embase, and Web of Science (WOS) databases was conducted using appropriate search strings. Deterministic modeling determined annual incidence and prevalence estimates for multiple life- and sight-threatening infections with significant morbidity.

RESULTS

Literature searches yielded >2900 papers; 434 papers with incidence/prevalence/proportion data were analyzed. An estimated 57 251 328 of the 1 393 400 000 people in India (4.1%) suffer from a serious fungal disease. The prevalence (in millions) of recurrent vulvovaginal candidiasis is 24.3, allergic bronchopulmonary aspergillosis is 2.0, tinea capitis in school-age children is 25, severe asthma with fungal sensitization is 1.36, chronic pulmonary aspergillosis is 1.74, and chronic fungal rhinosinusitis is 1.52. The annual incidence rates of pneumonia (58 400), invasive aspergillosis (250 900), mucormycosis (195 000), esophageal candidiasis in HIV (266 600), candidemia (188 000), fungal keratitis (1 017 100), and cryptococcal meningitis (11 500) were also determined. Histoplasmosis, talaromycosis, mycetoma, and chromoblastomycosis were less frequent.

CONCLUSIONS

India's fungal burden is high and underappreciated in clinical practice.

摘要

背景

真菌病在印度很常见,但其发病率和患病率尚不清楚。本综述旨在确定印度各种真菌感染的频率或负担。

方法

使用适当的检索词对PubMed、Embase和科学网(WOS)数据库中的文献进行系统综述。确定性建模确定了多种危及生命和视力且具有显著发病率的感染的年发病率和患病率估计值。

结果

文献检索得到>2900篇论文;分析了434篇有发病率/患病率/比例数据的论文。印度13.934亿人口中估计有57251328人(4.1%)患有严重真菌病。复发性外阴阴道念珠菌病的患病率(以百万计)为2430万,变应性支气管肺曲霉病为174万,学龄儿童头癣为2500万,真菌致敏的重度哮喘为136万,慢性肺曲霉病为174万,慢性真菌性鼻-鼻窦炎为152万。还确定了肺炎(58400例)、侵袭性曲霉病(250900例)、毛霉病(195000例)、HIV患者食管念珠菌病(266600例)、念珠菌血症(188000例)、真菌性角膜炎(1017100例)和隐球菌性脑膜炎(11500例)的年发病率。组织胞浆菌病、马拉色菌病、足菌肿和着色芽生菌病较少见。

结论

印度的真菌负担很高,在临床实践中未得到充分重视。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/9792086/f3dd2f18b8aa/ofac603f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/9792086/d229215606ff/ofac603f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/9792086/7eb1c0c5efc5/ofac603f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/9792086/f3dd2f18b8aa/ofac603f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/9792086/d229215606ff/ofac603f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/9792086/7eb1c0c5efc5/ofac603f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3acb/9792086/f3dd2f18b8aa/ofac603f3.jpg

相似文献

1
Burden of Serious Fungal Infections in India.印度严重真菌感染的负担
Open Forum Infect Dis. 2022 Dec 26;9(12):ofac603. doi: 10.1093/ofid/ofac603. eCollection 2022 Dec.
2
Estimated Incidence and Prevalence of Serious Fungal Infections in Morocco.摩洛哥严重真菌感染的估计发病率和患病率。
J Fungi (Basel). 2022 Apr 17;8(4):414. doi: 10.3390/jof8040414.
3
Estimated Burden of Serious Fungal Infections in Ghana.加纳严重真菌感染的估计负担。
J Fungi (Basel). 2019 May 11;5(2):38. doi: 10.3390/jof5020038.
4
Re-estimation of the burden of serious fungal diseases in Uganda.乌干达严重真菌病负担的重新估计。
Ther Adv Infect Dis. 2024 Feb 6;11:20499361241228345. doi: 10.1177/20499361241228345. eCollection 2024 Jan-Dec.
5
Estimated burden of fungal infections in Panama.巴拿马真菌感染负担的估计。
J Mycol Med. 2024 Mar;34(1):101466. doi: 10.1016/j.mycmed.2024.101466. Epub 2024 Feb 17.
6
Updated estimation of the burden of fungal disease in Vietnam.越南真菌病负担的最新估计。
Mycoses. 2023 Apr;66(4):346-353. doi: 10.1111/myc.13559. Epub 2023 Jan 6.
7
Updated estimated incidence and prevalence of serious fungal infections in Trinidad and Tobago.特立尼达和多巴哥严重真菌感染的最新估计发病率和患病率。
IJID Reg. 2021 Sep 27;1:34-40. doi: 10.1016/j.ijregi.2021.09.007. eCollection 2021 Dec.
8
Estimates of serious fungal infection burden in Côte d'Ivoire and country health profile.科特迪瓦严重真菌感染负担估计和国家卫生概况。
J Mycol Med. 2021 Mar;31(1):101086. doi: 10.1016/j.mycmed.2020.101086. Epub 2020 Nov 21.
9
Estimated Burden of Serious Fungal Infections in Jamaica by Literature Review and Modelling.通过文献综述和建模评估牙买加严重真菌感染的负担
West Indian Med J. 2015 Jun;64(3):245-9. doi: 10.7727/wimj.2014.204. Epub 2015 Apr 28.
10
Estimated burden of serious fungal infections in Togo.多哥严重真菌感染的估算负担。
Mycoses. 2021 Dec;64(12):1535-1541. doi: 10.1111/myc.13377. Epub 2021 Oct 13.

引用本文的文献

1
Comparative Clinical Characteristics and Outcomes of Candida (Candidozyma) auris vs. Non-C. auris Candidemia in Non-neutropenic Patients in South India.印度南部非中性粒细胞减少患者中耳念珠菌(解脂念珠菌)与非耳念珠菌念珠菌血症的临床特征及结局比较
Mycopathologia. 2025 Aug 15;190(5):72. doi: 10.1007/s11046-025-00974-2.
2
Azole resistance: patterns of amino acid substitutions in Candida sterol 14α-demethylase.唑类抗性:白色念珠菌固醇14α-去甲基酶中的氨基酸取代模式
Antonie Van Leeuwenhoek. 2025 Apr 17;118(5):68. doi: 10.1007/s10482-025-02080-1.
3
Histoplasmosis - More common than we realize.

本文引用的文献

1
New estimation of the prevalence of chronic pulmonary aspergillosis (CPA) related to pulmonary TB - a revised burden for India.与肺结核相关的慢性肺曲霉病(CPA)患病率的新估计——印度的修订负担。
IJID Reg. 2022 Nov 18;6:7-14. doi: 10.1016/j.ijregi.2022.11.005. eCollection 2023 Mar.
2
Global Dialysis Perspective: India.全球透析视角:印度
Kidney360. 2020 Aug 19;1(10):1143-1147. doi: 10.34067/KID.0003982020. eCollection 2020 Oct 29.
3
Risk factors for Coronavirus disease-associated mucormycosis.冠状病毒病相关毛霉菌病的危险因素。
组织胞浆菌病——比我们意识到的更常见。
IDCases. 2025 Feb 11;39:e02180. doi: 10.1016/j.idcr.2025.e02180. eCollection 2025.
4
Antifungal Policy and Practice Across Five Countries: A Qualitative Review.五个国家的抗真菌政策与实践:一项定性综述
J Fungi (Basel). 2025 Feb 19;11(2):162. doi: 10.3390/jof11020162.
5
Disseminated histoplasmosis from western Mexico-rethinking our geographic distribution of endemic fungal species: a case report and review of literature.墨西哥西部播散性组织胞浆菌病——重新思考我们地方性真菌物种的地理分布:病例报告和文献复习。
J Med Case Rep. 2024 Nov 8;18(1):540. doi: 10.1186/s13256-024-04856-x.
6
Invasive Fungal Infections in Immunocompromised Conditions: Emphasis on COVID-19.免疫功能低下人群中的侵袭性真菌感染:重点关注 COVID-19。
Curr Microbiol. 2024 Oct 9;81(11):400. doi: 10.1007/s00284-024-03916-1.
7
EpiCandIn: An open online resource for epidemiology of Candida infections in India.EpiCandIn:印度念珠菌感染流行病学的在线开放资源。
Indian J Med Res. 2024 Jun;159(6):576-580. doi: 10.25259/ijmr_886_23.
8
ISCCM Position Statement on the Management of Invasive Fungal Infections in the Intensive Care Unit.国际重症监护医学学会关于重症监护病房侵袭性真菌感染管理的立场声明。
Indian J Crit Care Med. 2024 Aug;28(Suppl 2):S20-S41. doi: 10.5005/jp-journals-10071-24747. Epub 2024 Aug 10.
9
Think Globally, Adapt Locally: The ISCCM Guidelines and Position Statements.全球思考,本土适应:国际危重症与急救医学学会指南及立场声明
Indian J Crit Care Med. 2024 Aug;28(Suppl 2):S1-S3. doi: 10.5005/jp-journals-10071-24784. Epub 2024 Aug 10.
10
Aflatoxin profiles of Aspergillus flavus isolates in Sudanese fungal rhinosinusitis.苏丹真菌性鼻窦炎中黄曲霉分离株的黄曲霉毒素谱
Med Mycol. 2024 Mar 28;62(4). doi: 10.1093/mmy/myae034.
J Infect. 2022 Mar;84(3):383-390. doi: 10.1016/j.jinf.2021.12.039. Epub 2021 Dec 30.
4
The global burden of chromoblastomycosis.黑曲霉病的全球负担。
PLoS Negl Trop Dis. 2021 Aug 12;15(8):e0009611. doi: 10.1371/journal.pntd.0009611. eCollection 2021 Aug.
5
Response to: COVID-19-associated mucormycosis and evolving evidence.回复:新型冠状病毒肺炎相关毛霉菌病及不断演变的证据
QJM. 2022 Jun 7;115(6):422. doi: 10.1093/qjmed/hcab191.
6
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究(COSMIC),报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
7
COVID-19-associated mucormycosis: an epidemic within a pandemic.新型冠状病毒肺炎相关毛霉菌病:大流行中的一种流行病。
QJM. 2021 Oct 7;114(6):355-356. doi: 10.1093/qjmed/hcab165.
8
Challenges of lung transplantation in India.印度肺移植面临的挑战。
Indian J Thorac Cardiovasc Surg. 2022 Jul;38(Suppl 2):229-236. doi: 10.1007/s12055-021-01170-9. Epub 2021 Apr 24.
9
The global incidence and diagnosis of fungal keratitis.真菌性角膜炎的全球发病与诊断。
Lancet Infect Dis. 2021 Mar;21(3):e49-e57. doi: 10.1016/S1473-3099(20)30448-5. Epub 2020 Oct 22.
10
The epidemiology and clinical spectrum of infections of the central nervous system in adults in north India.印度北部成人中枢神经系统感染的流行病学和临床谱。
Trop Doct. 2021 Jan;51(1):48-57. doi: 10.1177/0049475520959905. Epub 2020 Oct 6.